| IART |
Integra LifeSciences Holdings Corporation |
72%
|
Reciprocal relationship from IART graph: Reciprocal relationship from SMTI graph: Reciprocal relationship from IART graph: Reciprocal relationship from SMTI graph: Reciprocal relationship from IART g… |
| IART |
Integra LifeSciences Holdings Corporation |
72%
|
ting room etiquette and credentialing requirements. After completing their internal training, new hire field sales representatives participate in field training with experienced field trainers to get… |
| INFU |
InfuSystem Holdings, Inc. |
72%
|
Reciprocal relationship from INFU graph: for certain types of cancer because clinical evidence demonstrates superior outcomes. Payers’ recognition of this benefit is reflected in their relative reimb… |
| INFU |
InfuSystem Holdings, Inc. |
72%
|
ions, LLC”), we are seeking to simplify skin health, starting with wound care through a refined business plan. Through THP, we plan to offer a first of its kind value-based wound care program to paye… |
| APPLIED-NUTRITIONALS-LLC |
APPLIED-NUTRITIONALS-LLC |
62%
|
h new and existing U.S. markets. Cost of Goods Sold. Cost of goods sold for the three months ended March 31, 2026 was $1.9 million compared to $1.8 million for the three months ended March 31, 2025. … |
| BIOMIMETIC-INNOVATIONS-LIMITED |
BIOMIMETIC-INNOVATIONS-LIMITED |
62%
|
h new and existing U.S. markets. Cost of Goods Sold. Cost of goods sold for the three months ended March 31, 2026 was $1.9 million compared to $1.8 million for the three months ended March 31, 2025. … |
| CHEMOMOUTHPIECE-LLC |
CHEMOMOUTHPIECE-LLC |
62%
|
tones, and upon settlement, the Company paid BMI $ 2.4 million (€ 2.0 million) on July 1, 2025 in exchange for 4,116 additional ordinary shares of BMI, bringing the Company’s total ownership of BMI’s… |
| COMPANY-SANARA-MEDTECH-APPLIED-TECHNOLOGIES-LLC |
COMPANY-SANARA-MEDTECH-APPLIED-TECHNOLOGIES-LLC |
62%
|
h new and existing U.S. markets. Cost of Goods Sold. Cost of goods sold for the three months ended March 31, 2026 was $1.9 million compared to $1.8 million for the three months ended March 31, 2025. … |
| CRG-SERVICING-LLC |
CRG-SERVICING-LLC |
62%
|
h new and existing U.S. markets. Cost of Goods Sold. Cost of goods sold for the three months ended March 31, 2026 was $1.9 million compared to $1.8 million for the three months ended March 31, 2025. … |
| PRECISION-HEALING-INC |
PRECISION-HEALING-INC |
62%
|
percentage of total revenue. 43 Table of Contents Operating Expenses Selling, general and administrative (“SG&A”) consists primarily of salaries, sales commissions, benefits, bonuses and share-based … |
| SANARA-CMP-LLC |
SANARA-CMP-LLC |
62%
|
rship of BMI’s outstanding equity to approximately 9.678 % as of July 1, 2025. In September 2025, BMI achieved the final three milestones, and upon settlement, the Company paid BMI $ 2.4 million (€ 2… |
| SANARA-COLLAGEN-PEPTIDES-LLC |
SANARA-COLLAGEN-PEPTIDES-LLC |
62%
|
s a naturally derived, differentiated allograft matrix with robust handling properties. ALLOCYTE Plus is a human allograft cellular bone matrix containing bone-derived progenitor cells and conformabl… |
| SCENDIA-BIOLOGICS-LLC |
SCENDIA-BIOLOGICS-LLC |
62%
|
percentage of total revenue. 43 Table of Contents Operating Expenses Selling, general and administrative (“SG&A”) consists primarily of salaries, sales commissions, benefits, bonuses and share-based … |
| SI-HEALTHCARE-TECHNOLOGIES-LLC |
SI-HEALTHCARE-TECHNOLOGIES-LLC |
62%
|
tones, and upon settlement, the Company paid BMI $ 2.4 million (€ 2.0 million) on July 1, 2025 in exchange for 4,116 additional ordinary shares of BMI, bringing the Company’s total ownership of BMI’s… |
| SI-WOUND-CARE-LLC |
SI-WOUND-CARE-LLC |
62%
|
tones, and upon settlement, the Company paid BMI $ 2.4 million (€ 2.0 million) on July 1, 2025 in exchange for 4,116 additional ordinary shares of BMI, bringing the Company’s total ownership of BMI’s… |
